Who invested in Akeso Biomedical

3 rounds we have observed, with the 0 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Agtech

Follow Akeso Biomedical and see its new rounds in your feed. Start following

Funding summaryUpdated 15 Nov 2026

$5.2Mraised across 3 rounds since 2014, from 3 sources

$225KSeed$535KVenture$4.4MRound

Latest round: Round, $4.4MJun 2017
Step-upi: 8.2×
Investors: 0

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201520162017

$225KSeed$535KVenture$4.4MRound

First round: Seed, $225K
Biggest round: $4.4M
Usual gap between rounds: 23 months

The rounds

Jun 2017
Round$4.4M
No investor was named in the report.
Reported by FinSMEsSEC filing: $2.5M sold, first sale Mar 2016
Jul 2015
Venture$535K
No investor was named in the report.
From a historical funding recordSEC filing: $535K sold, first sale Jul 2015
Dec 2014
Seed$225K
No investor was named in the report.
From a historical funding recordSEC filing: $225K sold, first sale Dec 2014

Funding filed with regulators

Akeso Biomedical filed 7 raises, $5.5M in all. Filings say how much was sold and to how many investors; they never name the investors.

May 2023$25K2 investorsequity, debtof $200K offeredSEC Form D
Feb 2021$574K30 investorsequityof $1.0M offeredSEC Form D
Oct 2019$597K20 investorsequityof $3.0M offeredSEC Form D
May 2018$982K51 investorsequityof $2.5M offeredSEC Form D
Mar 2016$2.5M26 investorsequityof $5.0M offeredSEC Form D
Jul 2015$535K10 investorsequityof $1.0M offeredSEC Form D
Dec 2014$225K9 investorsequityof $500K offeredSEC Form D

Founders and team

From Akeso Biomedical's own website and the SEC filings it signed: 4 on the team.

Jerome MeierChief Operating Officer
Greg W. LeeChairman
Scott J RothBoard Member
Simon WilliamsExecutive Officer, Directori

On the board, as filediAnthony J SinskeyKevin Calvin OhashiRobert Calvin Goforth

Also claim to have backed them

This firm lists Akeso Biomedical as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.